UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016776
Receipt No. R000019460
Scientific Title A phase III, randomized, controlled study of mFOLFOX6 + bevacizumab combination therapy versus mFOLFOX6 + panitumumab combination therapy in chemotherapy-naive patients with KRAS/NRAS wild-type, incurable/unresectable, advanced/recurrent colorectal cancer
Date of disclosure of the study information 2015/03/23
Last modified on 2020/05/21 18:43:44

No. Disposal Last modified on Item of update
1 Insert 2015/03/11 17:07:04
2 Update 2015/03/24 10:16:19 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
3 Update 2015/03/24 10:20:46 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
4 Update 2015/03/24 10:25:35 Email
5 Update 2015/06/16 12:08:17 Key inclusion criteria
Key inclusion criteria
6 Update 2015/06/16 12:09:07 Recruitment status
7 Update 2016/09/12 09:02:01 Key exclusion criteria
8 Update 2016/09/12 09:03:45 Name of primary sponsor
Organization
9 Update 2017/06/14 19:05:53 Recruitment status
10 Update 2020/03/13 13:50:12 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL

Last name of contact person

Zip code
Address
Address
TEL
Address
Address
Name of primary sponsor
Institute
Institute
Department
Organization1
Address1
Tel1
Organization
Organization
Address
Address
Tel
Email
11 Update 2020/03/13 14:48:03 Primary outcomes
Primary outcomes
12 Update 2020/03/13 14:50:29 Key secondary outcomes
13 Update 2020/05/21 16:53:22 Organization
Organization
Address
Address
Tel
Email
Study ID_2
Org. issuing International ID_2
Org. issuing International ID_2
14 Update 2020/05/21 17:01:06 Date of IRB
Last follow-up date
15 Update 2020/05/21 18:43:44 Date of IRB


Contact us.